Whole genome analysis in patients with resected non-small cell lung cancer (WJOG16622L)
- Conditions
- on-small cell lung cancer
- Registration Number
- JPRN-UMIN000050729
- Lead Sponsor
- West Japan Oncology Group
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 200
Not provided
1) Localized or systemically active infection requiring treatment. 2) Pregnant women, lactating women, women who may be currently pregnant, or cases of unwillingness to use contraception. 3) Clinically problematic psychiatric disorders precluding enrollment. 4) Requirement of continuous systemic administration of steroid, and the current use of an immunosuppressant. 5) History of severe hypersensitivity 6) History of interstitial lung disease, drug-induced interstitial lung disease, idiopathic pulmonary fibrosis, radiation pneumonitis requiring steroid therapy, or active interstitial lung disease. 7) Others judged by the investigator to be unsuitable for this study.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method